LogFAQs > #952918195

@Metal_DK Not sure if you're still holding or rebought any RGBP now that it's back to these prices, but thoughts on the recent 8-Ks for the commons and the preferred shares? Not too familiar with these OTC stocks as I always just social arb hype trade them, but is it not incredibly sketchy that David Koos is CEO of all three companies doing business with each other? He's CEO of RGBP, their subsidiary KCL Therapeutics, and Zander that they made the deal with outlined in the 8-K. Just found that incredibly bizarre as I've never read any filing where that was the case.

That said, goddamn RGBPP screams insane run potential to me and I bought $14k worth before close. A fraction of the float of commons, more heavily shorted apparently, has some degree of true stability, and has actual institutional investors in LG Capital who own a decent chunk of the stock. It just doesn't seem to have any retail buyers when comparing the volume with the commons, but if some more whales came along, the 180% day RGBP did could look comical in comparison with that setup. Who knows if it ever happens, it needs retail buyers giving it hype, but if it does it could be the craziest run I've ever been in. Or at least give the run I got in AMC with - from 4 to 20 - a run for its money.

---

- Blur -
Welcome to your Divinity.